Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon

Clinical trial NCT03869866 · COMPLETED

Trial details

NCT number: NCT03869866
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Healthy Volunteers (Meningococcal Infection)

Start date: 2019-04-09
Primary completion: 2022-03-18
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.